If the shark pattern completes a bounce at 1.13, instead of 0.886, I will consider this a low risk swing into 0.382 and 0.618 retracements. Usually, one would trade this straight into a 0.5 retracement. I am not sure about the other larger possible pattern here. It's still just an idea; however, considering the recent price targets of $50 and $100, as well as,...
This name is set up perfectly for a squeeze. it gapped up big Wednesday morning after reporting positive top-line data in late-stage study of lung cancer combo drug. it inevitably pulled in tons of shorts due to its large gap but the stock held relatively well and even pushed up later in the day. the problem is that shorts see that they will most likely raise...
BYSI BeyondSpring drug, plinabulin, increased overall survival and improved other measures of disease while staving off a dangerous side effect associated with Chemotherapy. BeyondSpring is preparing to ask for plinabulin approval in the U.S. and China. On 8/4/2021 J. Pantginis from HC Wainwright brokerage Upgraded BYSI BeyondSpring from Neutral to Buy giving...
Someone is loading up on this, several positive earnings surprises followed by a few hiccups. This is a strong swing play or a solid long play.
BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin...